Basic Search  |  Summaries  |  Advanced SearchPenalty: £10,101,954
Year: 2020
Date: 9 July, 2020
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Aspen Pharmacare Holdings Limited, Aspen Global Inc., Aspen Pharma Ireland Limited and Aspen Pharma Trading Limited paid a £2,101,954 fine and £8,000,000 to the NHS in settlement of a decision by the CMA that the companies colluded with Amilco and Tiofarma to maintain Aspen's position as the sole supplier of the drug fludrocortisone in the UK, which increased in price up to 1800% during the agreement. All companies involved admitted to anti-competitive behaviour in a settlement.
Action Type: agency action
Settlement Type: Settlement with the CMA
Case Number: 50455
Agency: Competition and Markets Authority
Source of Data: (click here)